Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Jan 07, 2022 6:33pm
195 Views
Post# 34295002

RE:RE:RE:RE:RE:RE:Something big is likely in the works

RE:RE:RE:RE:RE:RE:Something big is likely in the worksSo it seems that it is indeed a fact!!!! My first reaction is that I think it is a very bad idea.....My suspicious side thinks that they are on the verge of accepting a buy out and they will need at least 2/3 of approval by shareholders or even 90% to force dissenting shareholders to tender their shares,,,,,,,The other possibility is the need  to raise capital at unfavorable terms (ie high dilution)  .......I dont like the smell but hope to be proven wrong

SPCEO1 wrote: I was invited both to two meetings I am aware of (one on 1/24 and one on 1/25) and the company also offered to meet me where I live as well. The large shareholders do not represent a controlling interest.

TH called these shareholders and offered to meet, so the company instigated the meetings. I think it is safe to presume that some sort of info will be publically announced prior to those meetings. Could be good info or it could be bad, we can't know. Since the company instigated the meetings, the likelihood is it is good info. Also, given all the other signs we have seen, good info seems like a good bet. But, it could be good and bad both too. Or it could be bad info and the company is looking to meet with major shareholders in order to cut another shareholder revolt off at the pass. Finally, the meetings might have been set up without regard to any possible news items and simply because they wanted to mend relationships with shareholders who they burned in last year's offering. And I am sure I overlooked some other possibilities too.

So, we cannot really know what this is all about but given the weight of evidence, I am guessing it is mostly good news. 
PWIB123 wrote: @SPCE01 I'm assuming based on your comments you weren't invited to the large shareholder meeting.  I would have presumed you would've been invited since you represent such a large group of shareholders.  Were you not invited?  Do the large shareholders represent a controlling interest?




<< Previous
Bullboard Posts
Next >>